These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [New possibilities in the therapy of diabetes; critical report on an oral antidiabetic drug]. STEIGERWALDT F Med Monatsschr; 1955 Dec; 9(12):793-5. PubMed ID: 13296832 [No Abstract] [Full Text] [Related]
14. [Preliminary experience with the oral antidiabetic remedy BZ 55]. SVANBORG A; SOLVELL L Sven Lakartidn; 1956 May; 53(20):1311-20. PubMed ID: 13337651 [No Abstract] [Full Text] [Related]
15. [Clinical experience with the oral antidiabetic remedy invenol]. SCHNEEWEISS J; GASSMANN W; BUDING A Arztl Wochensch; 1956 Mar; 11(12):266-8. PubMed ID: 13326744 [No Abstract] [Full Text] [Related]
16. [A new antidiabetic sulfamide; clinical indications and dosage]. RAVINA A Presse Med (1893); 1956 Apr; 64(28):646-9. PubMed ID: 13335855 [No Abstract] [Full Text] [Related]
17. Trial of an oral hypoglycaemic agent in diabetes. WOLFF FW; STEWART GA; CROWLEY MF; BLOOM A Br Med J; 1956 Aug; 2(4990):440-5. PubMed ID: 13342508 [No Abstract] [Full Text] [Related]
18. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus. DIENGOTT D; DOLGER H; MIRSKY IA Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057 [No Abstract] [Full Text] [Related]
19. [Critical study of the mechanism of action of the oral anti-diabetic agent, nadisan]. FRAENKEL KA; SCHULZ K Dtsch Med J; 1956 Apr; 7(8):209-14. PubMed ID: 13344175 [No Abstract] [Full Text] [Related]
20. [BZ-55, a peroral antidiabetic remedy with a possible glucagon-restraining effect]. ANDERSSON B Sven Lakartidn; 1956 Jan; 53(2):57-64. PubMed ID: 13311777 [No Abstract] [Full Text] [Related] [Next] [New Search]